Nebula Genomics
ProPhase Labs to Repurchase $6M of Common Stock
The company plans to repurchase up to $6 million of its common shares over a six-month period, which the company's board will periodically reevaluate.
The company plans to repurchase up to $6 million of its common shares over a six-month period, which the company's board will periodically reevaluate.